Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord blood mesenchymal stem cell-derived insulin-producing cells
- Development stage
- Preclinical
- Lead developer
- LifeStem
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Injection
01
Overview
Umbilical cord blood mesenchymal stem cell-derived insulin-producing cells is a cell therapy program under development by LifeStem for the treatment of diabetes. The approach involves the in vitro differentiation of mesenchymal stem cells (MSCs) harvested from umbilical cord blood into functional insulin-producing cells (IPCs) that mimic the behavior of pancreatic beta cells. These cells are designed to sense blood glucose levels and secrete insulin accordingly, aiming to restore endogenous glycemic control and reduce the dependency on exogenous insulin administration. This therapy utilizes the regenerative and immunomodulatory potential of umbilical cord-derived stem cells to address the underlying cell deficiency in diabetic patients.
- Other names
- UC BMSC-derived insulin-producing cellsstem cell–derived insulin-producing cellsLifeStem insulin-producing cells
Beyond the preview
Go deeper on umbilical cord blood mesenchymal stem cell-derived insulin-producing cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord blood mesenchymal stem cell-derived insulin-producing cells.